Impact of Patient Support From Medical Staff on the Adherence to Therapy With PegIntron Plus Rebetol.

Trial Profile

Impact of Patient Support From Medical Staff on the Adherence to Therapy With PegIntron Plus Rebetol.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Dec 2013

At a glance

  • Drugs Peginterferon alfa-2b; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Dec 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 21 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top